Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Arkema's Nanostructured Materials at the Heart of the Genesis Research Program

Abstract:
The European Commission today has given its green light for the funding by OSEO1, amounting to € 46 M out of a total cost of € 107 M, of the Genesis program, coordinated by Arkema (Paris:AKE), which is opening the way for the development in Europe of an innovative and competitive sector in nanostructured materials.

Arkema's Nanostructured Materials at the Heart of the Genesis Research Program

France | Posted on June 4th, 2008

The Genesis program pools around Arkema, a leader in nanostructured materials and the sole producer in Europe of functional copolymers with controlled architecture, major industrial groups, SMEs, and several university laboratories within a partnership bringing directly together the design of materials and their applications in a number of markets earmarked for their technological innovation potential: automotive, cable, structural composites, energy, environment, as well as information and communication technologies.

With its essential contribution to the Genesis program, Arkema stands out as the foremost supplier of innovative nanostructured materials whose outstanding performances - mechanical strength, thermal and electrical properties, light weight - are poised to lead to technological breakthroughs in many sectors of industry.

####

About Arkema
" Arkema, France’s leading chemicals producer, now fully controls on a laboratory scale the mechanisms governing the synthesis of carbon nanotubes and copolymers with controlled architecture. The Genesis program will allow us to speed up the industrial development of nanostructured materials in direct cooperation with the relevant user sectors. We could witness the first commercial applications by 2009 / 2010 ", Christian Collette, Arkema Research & Development Vice President, is delighted to announce.

In keeping with Arkema’s sustainable development policy, the Genesis program favors the operation of clean processes, the use of renewable raw materials, and the inclusion of recycling considerations for end-of-life materials. It also devotes a major part to the toxicological and ecotoxicological properties of nanomaterials.

A global chemical company and France’s leading chemicals producer, Arkema consists of three strategically related businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reported sales of 5.7 billion euros. Arkema has 15,200 employees in over 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.

1 French public body which provides funding and assistance for industrial innovation

For more information, please click here

Contacts:
ARKEMA
420, rue d’Etienne d’Orves
F-92705 COLOMBES Cedex
Standard : +33 (0)1 49 00 80 80 -
Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 610 722 850 euros
445 074 685 RCS Nanterre

INVESTOR RELATIONS:
Frédéric Gauvard
Tel. : +33 1 49 00 82 53

or
Sophie Fouillat
Tel. : +33 1 49 00 86 37

or
PRESS CONTACTS:
Jacques Badaroux
Tel. : +33 1 49 00 71 34

or
Sybille Chaix
Tel. : +33 1 49 00 70 30

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

Materials/Metamaterials

Exploring phosphorene, a promising new material April 29th, 2016

Hybrid nanoantennas -- next-generation platform for ultradense data recording April 28th, 2016

NREL finds nanotube semiconductors well-suited for PV systems April 27th, 2016

Atomic magnets using hydrogen and graphene April 27th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic